Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Hormone Injections Can Spread ‘Seeds’ of Alzheimer’s, Study Says

September 10, 2015 12:51 pm | by Seth Augenstein, Digital Reporter | News | Comments

The “seeds” of Alzheimer’s and related brain diseases may be transmitted by direct tissue transplantation, according to a new study. Read more...


Global NSCL Cancer Treatment Market Value to Approach $11B by 2021

September 10, 2015 12:49 pm | by Joshua Libberton, Analyst, GBI Research | News | Comments

These new therapies will capture a significant share of the second-line treatment space. Read more...


Valeant, Progenics Announce FDA Acceptance of NDA Submission for Oral Relistor

September 10, 2015 12:39 pm | News | Comments

Relistor subcutaneous injection has been FDA approved since 2008 to treat OIC in patients with advanced illness who are receiving palliative care. Read more...


HIV Self-Testing Found Safe, Acceptable, and Accurate in Malawi Study

September 10, 2015 12:31 pm | by London School of Hygiene & Tropical Medicine | News | Comments

In sub-Saharan Africa, only one quarter of adults have had a recent test and only half of people with HIV know their status. Read more...


UQ Scientists Close in On First Dengue Treatment

September 10, 2015 12:22 pm | by University of Queensland | News | Comments

Clinical trials for a dengue fever treatment could start within a year. Read more...


Certara, Paidion Research Form Partnership Focused on Improving Pediatric Drug Development

September 10, 2015 11:54 am | News | Comments

Certara, the global biosimulation technology-enabled drug development company, and Paidion Research, Inc., a pediatric clinical research organization (CRO), announced a new partnership dedicated to promoting more efficient and reliable drug development for pediatric patients. Read more...


Lasker Awards Given to Studies of Cancer, DNA Damage

September 10, 2015 10:54 am | by Malcomb Ritter, Associated Press | News | Comments

Three researchers won prestigious medical awards this week for a new approach to treating cancer and insights into how creatures deal with DNA damage. Read more...


Cell Surface Discovery May Lead to Major Breakthrough in Cancer Treatment

September 10, 2015 10:03 am | by University of Virginia | News | Comments

​University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease. By more selectively targeting cancer cells, this method offers a strategy to reduce the length of and physical toll associated with current treatments. Read more...


Diabetes Drug Boosts Bone Fat and Fracture Risk

September 10, 2015 9:47 am | by UNC Health Care | News | Comments

A new UNC School of Medicine study visualizes the dramatic influence of a diabetes drug on bone health and the benefit of exercise in mice. Read more...


DelMar: Updated Phase 1/2 Data on VAL-083 in Refractory Glioblastoma Multiforme

September 10, 2015 9:41 am | News | Comments

DelMar Pharmaceuticals today presented updated clinical data from its Phase 1/2 study of lead product candidate VAL-083 (dianhydrogalactitol), in patients with refractory glioblastoma multiforme (GBM), at GBM2015: 2nd International Symposium on Clinical and Basic Investigation in Glioblastoma in Toledo, Spain. Read more...


Diabetes Research Institute's First Patient In BioHub Trial No Longer Requires Insulin Therapy

September 10, 2015 9:27 am | by Diabetes Research Institute | News | Comments

The Diabetes Research Institute (DRI), a Center of Excellence at the University of Miami Miller School of Medicine, announced today that the first patient transplanted in its clinical trial has been free from insulin injections in record time following the implantation of islet cells within a biological scaffold. Read more...


Regulators Halt Study of Cancer Risks at 7 Nuclear Plants

September 10, 2015 9:16 am | by Stephen Singer, Associated Press | News | Comments

Federal regulators are pulling the plug on a five-year study of the risk of cancer in communities around six U.S. nuclear plants and a nuclear fuel site. Read more...


Express Scripts Says George Paz Will Step Down as CEO in May

September 10, 2015 9:11 am | by Associated Press | News | Comments

Express Scripts, the largest pharmacy benefits management company in the U.S., said Wednesday that George Paz will retire as its CEO in May. Read more...


3D Barcode May Prevent Drug Counterfeiting

September 10, 2015 8:00 am | by Ryan Bushey, Associate Editor | News | Comments

A specialized barcode unveiled at the British Science Festival on Wednesday may play an important role in combatting the global proliferation of fake medications. Read more...


Global Allergic Rhinitis Treatment Market to Remain Stagnant over Next Decade

September 10, 2015 7:45 am | by Claire Gibson, Ph.D., Managing Analyst, GlobalData | News | Comments

The introduction of US Food & Drug Administration (FDA)-approved OTC intranasal corticosteroids (INCS) in the US is set to have a particularly negative impact on the prescription drug treatment rate. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.